A preliminary study on treatment of human breast cancer xenografts with a cocktail of paclitaxel, doxorubicin, and (131)I-anti-epithelial cell adhesion molecule (9C4)

Triple-negative breast cancer often has devastating outcomes and treatment options remain limited. Therefore, different treatment combinations are worthy of testing. The efficacy of a cocktail of paclitaxel, doxorubicin, and (131)I-anti-epithelial cell adhesion molecule (EpCAM) (9C4) to treat breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Naiim S., Akudugu, John M., Howell, Roger W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357706/
https://www.ncbi.nlm.nih.gov/pubmed/30774541
http://dx.doi.org/10.4103/wjnm.WJNM_9_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357706/
https://www.ncbi.nlm.nih.gov/pubmed/30774541
http://dx.doi.org/10.4103/wjnm.WJNM_9_18

Ejemplares similares